U.S. Markets open in 1 hr 13 mins
  • S&P Futures

    3,659.75
    +36.50 (+1.01%)
     
  • Dow Futures

    29,947.00
    +318.00 (+1.07%)
     
  • Nasdaq Futures

    12,392.50
    +115.50 (+0.94%)
     
  • Russell 2000 Futures

    1,845.30
    +25.20 (+1.38%)
     
  • Crude Oil

    45.11
    -0.23 (-0.51%)
     
  • Gold

    1,811.50
    +30.60 (+1.72%)
     
  • Silver

    23.52
    +0.93 (+4.10%)
     
  • EUR/USD

    1.1972
    +0.0037 (+0.3113%)
     
  • 10-Yr Bond

    0.8440
    0.0000 (0.00%)
     
  • Vix

    20.19
    -0.65 (-3.12%)
     
  • GBP/USD

    1.3328
    -0.0004 (-0.0267%)
     
  • USD/JPY

    104.3810
    +0.0570 (+0.0546%)
     
  • BTC-USD

    18,437.15
    -962.62 (-4.96%)
     
  • CMC Crypto 200

    361.14
    -3.45 (-0.95%)
     
  • FTSE 100

    6,385.03
    +118.84 (+1.90%)
     
  • Nikkei 225

    26,787.54
    +353.92 (+1.34%)
     

Charles River Laboratories International Inc (CRL) Chairman, President and CEO James C Foster ...

GuruFocus.com
·1 min read

- By insider

Chairman, President and CEO of Charles River Laboratories International Inc (30-Year Financial, Insider Trades) James C Foster (insider trades) sold 22,000 shares of CRL on 11/02/2020 at an average price of $232.38 a share. The total sale was $5.1 million.


Charles River Laboratories International Inc is a pharmaceutical company providing drug discovery and development services. The company provides animal models for laboratory testing, and offers manufacturing testing services to various industries. Charles River Laboratories International Inc has a market cap of $11.81 billion; its shares were traded at around $237.45 with a P/E ratio of 39.55 and P/S ratio of 4.21. Charles River Laboratories International Inc had annual average EBITDA growth of 14.70% over the past five years. GuruFocus has detected 1 severe warning sign with Charles River Laboratories International Inc. .

CEO Recent Trades:

  • Chairman, President and CEO James C Foster sold 22,000 shares of CRL stock on 11/02/2020 at the average price of $232.38. The price of the stock has increased by 2.18% since.

Directors and Officers Recent Trades:

  • Director Richard F Wallman bought 7,200 shares of CRL stock on 11/02/2020 at the average price of $233.2. The price of the stock has increased by 1.82% since.

For the complete insider trading history of CRL, click here

.This article first appeared on GuruFocus.